Zabedosertib
| CAS No. | 1931994-81-8 | Cat. No. | BCP44094 |
| Name | Zabedosertib | ||
| Synonyms | BAY 1834845; BAY1834845; BAY-1834845; | ||
| Formula | C20H21F3N4O4S | M. Wt | 470.47 |
| Description | Zabedosertib, also known as BAY 1834845, is a IRAK-4 inhibitor. IRAK-4 inhibitors are an exciting therapeutic option in RA management because unlike other targeted disease-modifying agents, they target the innate immune system. The role of IRAK-4 as a key component of Toll/Interleukin-1 receptor signaling and its potential for a low rate of infectious complications is particularly exciting and this may facilitate their use in combination treatment. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | IRAK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.